Choline acetyltransferase activity in vascular dementia and stroke

Dementia and Geriatric Cognitive Disorders

Volumn 28, Issue 3, 2009, Pages 233-238

  Sharp, Sally I ^a   Francis, Paul T ^a   Elliott, Mark S J ^a   Kalaria, Rajesh N ^b   Bajic, Natasha ^a   Hortobagyi, Tibor ^a   Ballard, Clive G ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Choline acetyltransferase; Cognition; Vascular dementia

Indexed keywords

CHOLINE ACETYLTRANSFERASE;

ALZHEIMER DISEASE; ARTICLE; COGNITION; ENZYME ACTIVITY; HUMAN; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; PROTEIN FUNCTION; SCORING SYSTEM; STROKE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CEREBRAL INFARCTION; CHOLINE O-ACETYLTRANSFERASE; DEMENTIA, VASCULAR; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREFRONTAL CORTEX; STROKE; TEMPORAL LOBE;

EID: 70349264451     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000239235     Document Type: Article

References (32)

1. Ballard C, Rowan E, Stephens S, Kalaria R, Kenny RA: Prospective follow-up study between 3 and 15 months after stroke: improvements and decline in cognitive function among dementia-free stroke survivors 1 75 years of age. Stroke 2003; 34: 2440-2444.
2. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM: Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology 1996; 46: 154-159.
3. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST: Vascular cognitive impairment. Lancet Neurol 2003; 2: 89-98.
4. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, Peterson BL, Pieper CF: Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 1998; 51: 159-162.
5. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-260.
6. Gottfries CG, Blennow K, Karlsson I, Wallin A: The neurochemistry of vascular dementia. Dementia 1994; 5: 163-167.
7. Perry E, Ziabreva I, Perry R, Aarsland D, Ballard C: Absence of cholinergic deficits in 'pure' vascular dementia. Neurology 2005; 64: 132-133.
8. Keverne JS, Low WC, Ziabreva I, Court JA, Oakley AE, Kalaria RN: Cholinergic neuronal deficits in CADASIL. Stroke 2007; 38: 188-191.
9. Kalaria RN, Ballard C: Stroke and cognition. Curr Atheroscler Rep 2001; 3: 334-339.
10. Mesulam M, Siddique T, Cohen B: Cholinergic denervation in a pure multi-infarct state: observations on CADASIL. Neurology 2003; 60: 1183-1185.
11. Jellinger K, Riederer P, Kothbauer P: Brain monoamines in human cerebral infarcts: a preliminary study. Acta Neuropathol 1978; 41: 173-176.
12. Folstein MF, Folstein S, McHugh PR: 'Mini- Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975; 12: 189-198.
13. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Browntee LM, Vogel FS, Hughes JP, VanBelle G, Berg L: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
14. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropath 1991; 82: 239-259.
15. World Health Organization: The ICD10 Classification of Mental and Behavioural Disorders. Geneva, WHO, 1992.
16. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed III-R. Washington, APA, 1987.
17. Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T: Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 2004; 226: 75-80.
18. Lewis H, Beher D, Cookson N, Oakley A, Piggott M, Morris CM, Jaros E, Perry R, Ince P, Kenny RA, Ballard CG, Shearman MS, Kalaria RN: Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia. Neuropathol Appl Neurobiol 2006; 32: 103-118.
19. Gold G, Bouras C, Canuto A, Bergallo MF, Herrmann FR, Hof PR, Mayor PA, Michel JP, Giannakopoulos P: Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Am J Psychiatry 2002; 159: 82-87.
20. Minger SL, Esiri MM, McDonald B, Keene J, Carter J, Hope T, Francis PT: Cholinergic deficits contribute to behavioural disturbance in patients with dementia. Neurology 2000; 55: 1460-1467.
21. Fonnum F: A rapid radiochemical method for the determination of choline acetyltransferase activity. J Neurochem 1975; 24: 407-409.
22. Davies P: Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res 1979; 171: 319-327.
23. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV: Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 2002; 359: 1283-1290. (Pubitemid 34310633)
24. Moretti R, Torre P, Antonello RM, Clazzato G, Pizzolato G: Different responses to rivastigmine in subcortical vascular dementia and multi-infarct dementia. Am J Alzheimers Dis Other Demen 2008; 23: 167-176.
25. Mesulam M, Siddique T, Cohen B: Cholinergic denervation in a pure multi-infarct state: observations on CADASIL. Neurology 2003; 60: 1183-1185.
26. DeKosky ST, Ikonomovic MD, Styren SD, Beckett L, Wisniewski S, Bennett DA, Cochran EJ, Kordower JH, Mufson EJ: Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002; 51: 145-155.
27. Ikonomovic MD, Mufson EJ, Wuu J, Cochran EJ, Bennett DA, DeKosky ST: Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology. J Alz heimers Dis 2003; 5: 39-48.
28. Elliott MSJ, Ballard CG, Kalaria RN, Perry RH, Hortobagyi T, Francis PT: Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognition. Brain 2009; 132: 1858-1865.
29. Hayashi T, Noshita N, Sugawara T, Chan PH: Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J Cereb Blood Flow Metab 2003; 23: 166-180.
30. Kaneko N, Sawamoto K: Adult neurogenesis and its alteration under pathological conditions. Neurosci Res 2009; 63: 155-164.
31. Hou SW, Wang YQ, Xu M, Shen DH, Wang JJ, Huang F, Yu Z, Sun FY: Functional integration of newly generated neurons into striatum after cerebral ischemia in the adult rat brain. Stroke 2008; 39: 2837-2844.
32. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, Jiang H, Zhang C, Lu M, Katakowski M, Feldkamp CS, Chopp M: Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 2003; 53: 743-751.